Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Demant (WILLF) vs. Competitors

30 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
WILLFDemant$55.04$11.23B48.0255.81%Moderate BuyUnlock the WILLF analyst price target with TipRanks PremiumWILLFUnlock the WILLF top-analyst price target with TipRanks Premium
HAEHaemonetics$120.54$5.57B53.1068.05%Strong BuyUnlock the HAE analyst price target with TipRanks PremiumWILLF vs HAEUnlock the HAE top-analyst price target with TipRanks Premium
BSXBoston Scientific$45.13$64.79B19.04-55.97%Moderate BuyUnlock the BSX analyst price target with TipRanks PremiumWILLF vs BSXUnlock the BSX top-analyst price target with TipRanks Premium
IARTIntegra Lifesciences$14.77$1.13B88.0219.79%HoldUnlock the IART analyst price target with TipRanks PremiumWILLF vs IARTUnlock the IART top-analyst price target with TipRanks Premium
ISRGIntuitive Surgical$449.53$156.00B53.71-21.43%Strong BuyUnlock the ISRG analyst price target with TipRanks PremiumWILLF vs ISRGUnlock the ISRG top-analyst price target with TipRanks Premium
MDTMedtronic$101.61$129.95B24.846.51%Moderate BuyUnlock the MDT analyst price target with TipRanks PremiumWILLF vs MDTUnlock the MDT top-analyst price target with TipRanks Premium
SNNSmith & Nephew Snats$31.04$12.65B20.18-6.73%HoldUnlock the SNN analyst price target with TipRanks PremiumWILLF vs SNNUnlock the SNN top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
WILLFDemant55.0419.7255.83%
HAEHaemonetics120.5447.4264.85%
BSXBoston Scientific45.13-59.00-56.66%
IARTIntegra Lifesciences14.772.6822.17%
ISRGIntuitive Surgical449.53-122.92-21.47%
MDTMedtronic101.618.879.57%
SNNSmith & Nephew Snats31.04-1.58-4.83%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts